Literature DB >> 6573286

HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.

J McCluskey, V J McCann, P H Kay, P J Zilko, F T Christiansen, G J O'Neill, R L Dawkins.   

Abstract

A group of patients with Type 1 (insulin-dependent) diabetes mellitus was investigated for HLA-A, B and DR antigens as well as C4 and factor B polymorphism. A significant excess of DR3/DR4 heterozygotes was observed (27% versus 17% by Hardy-Weinberg expectation). The factor B allele BfF1 was present in 13% of patients with Type 1 diabetes (gene frequency of 0.08 versus 0.01 in control subjects). A rare C4 B allele, C4 B2.9, was found in 18% of patients with Type 1 diabetes (n = 63) compared with 1.1% of control subjects (n = 176). Total C4 deficiency at the C4 A locus (C4 AQ0,0) was present in 10% of patients with Type 1 diabetes compared with 0% of control subjects. Examination of HLA, C4 and Bf phenotypes in patients with Type 1 diabetes suggested that three high risk supratypes, HLA-A1 B8 BfS C4 AQ0 C4 B1 DR3; HLA-B18 BfF1 C4 A3 C4 BQ0 DR3; HLA-A2 CW3 BW62 BfS C4 A3 C4 B2.9 DR4 are markers for susceptibility alleles.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573286     DOI: 10.1007/bf00250155

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  C4: another marker for type I diabetes.

Authors:  J Bertrams; U Hintzen; V Schlicht; S Schoeps
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

3.  Genetic marker for insulin-dependent diabetes mellitus.

Authors:  D Raum; C A Alper; R Stein; K H Gabbay
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

4.  Complement allotyping reveals new genetic markers in rheumatoid arthritis and diabetes mellitus.

Authors:  P H Kay; J McCluskey; F T Christiansen; D Feeney; V J McCann; P J Zilko; R L Dawkins; G J O'Neill
Journal:  Tissue Antigens       Date:  1983-02

Review 5.  On the significance of C2, C4, and factor B polymorphisms in disease.

Authors:  C Rittner; J Bertrams
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Genetic heterogeneity of diabetes and HLA.

Authors:  J Barbosa; F H Bach; S S Rich
Journal:  Clin Genet       Date:  1982-01       Impact factor: 4.438

7.  Properdin factor B(Bf) allele BfF1 specifies an HLA-B18 diabetogenic haplotype.

Authors:  J Dornan; P Allan; E P Noel; B Larsen; N R Farid
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

8.  Glyoxalase phenotypes in patients with diabetes mellitus.

Authors:  V J McCann; R E Davis; T A Welborn; I J Constable; D G Beale
Journal:  Aust N Z J Med       Date:  1981-08

9.  Age-related association of insulin-dependent diabetes mellitus with BfF1 and the HLA-B18, BfF1 haplotype.

Authors:  J Bertrams; M P Baur; D Grüneklee; F A Gries
Journal:  Diabetologia       Date:  1981-07       Impact factor: 10.122

10.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  14 in total

1.  Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles.

Authors:  G Uko; F T Christiansen; R L Dawkins; V J McCann
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

2.  Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.

Authors:  G Senaldi; B A Millward; M J Hussain; D A Pyke; R D Leslie; D Vergani
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

Review 3.  Do genetic factors play a role in the pathogenesis of diabetic microangiopathy?

Authors:  J Barbosa; B Saner
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

4.  A DR3-related DX alpha gene polymorphism strongly associates with insulin-dependent diabetes mellitus.

Authors:  G A Hitman; J Sachs; P Cassell; J Awad; G F Bottazzo; A C Tarn; G Schwartz; J P Monson; H Festenstein
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes.

Authors:  A H Barnett; C Mijovic; J Fletcher; I Chesner; B M Kulkuska-Langlands; R Holder; A R Bradwell
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

6.  Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.

Authors:  P Ruuska; J Ilonen; A Mustonen; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

7.  The complement system in type 1 (insulin-dependent) diabetes.

Authors:  J A Charlesworth; V Timmermans; J Golding; L V Campbell; P W Peake; B A Pussell; D Wakefield; N Howard
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

8.  Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.

Authors:  H Kelly; V J McCann; P H Kay; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and associations with distinct HLA haplotypes in German Caucasians.

Authors:  D J Schendel; G J O'Neill; R Wank
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  Extended major histocompatibility complex haplotypes in type I diabetes mellitus.

Authors:  D Raum; Z Awdeh; E J Yunis; C A Alper; K H Gabbay
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.